DaVitaMEX:DVA 80 OCF Yield % is 14.38 as of Jun. 30, 2026, which is 16% below its 10-year median of 17.17. GuruFocus rates MEX:DVA with a GF Score™ of 80/100 and a GF Value™ of MXN2,657.13 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 683 Healthcare Providers & Services companies, DaVita ranks better than 79.8% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for DaVita's OCF Yield % or its related term are showing as below:
MEX:DVA'
s OCF Yield % Range Over the Past 10 Years
Min: 10.56 Med: 17.17 Max: 27.86
Current: 14.38
During the past 13 years, the highest OCF Yield % of DaVita was 27.86%. The lowest was 10.56%. And the median was 17.17%.
MEX:DVA's OCF Yield % is ranked better than 79.8% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 5.51
vs MEX:DVA: 14.38
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
DaVita OCF Yield % Related Terms
DaVita OCF Yield % Historical Data
* Premium members only.
The historical data trend for DaVita's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, DaVita's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DaVita OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DaVita's OCF Yield % distribution charts can be found below:
* The bar in red indicates where DaVita's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DaVita (MEX:DVA) has a OCF Yield % of 14.38 as of Jun. 30, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on DaVita and its competitors. This is 16% below median its historical median of 17.17. Over the past decade, DaVita's OCF Yield % has ranged from 10.56 to 27.86. According to the industry distribution chart, DaVita ranks #138 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 20.2%.
Is DaVita's OCF Yield % too high?
DaVita's current OCF Yield % of 14.38 is 16% below median its 10-year median of 17.17. Over the past 10 years, this metric has ranged from a low of 10.56 to a high of 27.86. The Healthcare Providers & Services industry median OCF Yield % is 5.51. DaVita's value of 14.38 is 161% above this industry median. Based on the distribution chart, DaVita ranks #138 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DaVita has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DaVita's OCF Yield % compare to THC and EHC?
According to the Healthcare Providers & Services industry distribution chart, DaVita ranks #138 out of 683 companies for OCF Yield %. This places DaVita in the top 20% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 5.51. DaVita's value of 14.38 is 161% above this benchmark. Historically, DaVita's own OCF Yield % has ranged from 10.56 to 27.86 over the past decade. While the company's 10-year median is 17.17 vs. the industry median of 5.51, DaVita has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.51, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DaVita's current OCF Yield % of 14.38 is 161% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on DaVita and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DaVita's current OCF Yield % is 14.38, which is 16% below median its own 10-year median of 17.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (MEX:DVA) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN2,657.13, compared to a current price of MXN3,358.09 — trading 26.4% above its estimated fair value. The current OCF Yield % is 14.38, which is 16% below median its 10-year median of 17.17 and 161% above the Healthcare Providers & Services industry median of 5.51. DaVita's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For DaVita (MEX:DVA), the current OCF Yield % is 14.38 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DaVita (MEX:DVA) Overvalued in 2026?
Based on GuruFocus' analysis, DaVita stock appears to be overvalued.
The current stock price of MXN3,358.09 is trading 26.4% above its estimated GF Value™ of MXN2,657.13.
GuruFocus considers DaVita to be Modestly Overvalued.
Key valuation signals for MEX:DVA:
OCF Yield %: 14.38 (16% below median its 10-year median of 17.17)
GF Value™: MXN2,657.13 vs. price of MXN3,358.09 (26.4% above fair value)
Industry Position: 161% above the Healthcare Providers & Services median (#138 of 683)
No single metric tells the full story. See the MEX:DVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
80GF Score
Get the complete analysis for MEX:DVA
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:DVA has been successfully added to your 
